Is a Reverse Acquihire Legal, or Am I Signing Up for an Antitrust Investigation?

A major technology company approaches your startup. They want your entire engineering team. They also want a license to your technology.

There is no traditional stock purchase. No asset purchase agreement. No lengthy acquisition process.

Instead, you receive employment offers for your team and a licensing agreement for the company’s intellectual property.

It sounds fast.

Your employees get new jobs. Your investors may get liquidity. The acquiring company gets the people and technology it wants.

But there is a problem.

Regulators are increasingly looking at whether arrangements like this are actually mergers structured to avoid traditional antitrust review. The distinction matters because calling a transaction a “hire-and-license” deal does not necessarily determine how regulators will view it.

What Is a Reverse Acquihire?

A reverse acquihire, sometimes described as a hire-and-license transaction, occurs when another company hires a startup’s team and licenses its intellectual property instead of formally acquiring the company.

On paper, it can look like two separate transactions.

One agreement covers employment.

Another covers intellectual property licensing.

But regulators may look beyond the paperwork and examine what the transaction actually accomplishes.

If the arrangement effectively transfers the people, technology, and economic value of the startup to another company, regulators may question whether it is really a merger structured to avoid antitrust review.

The Antitrust Theory Is No Longer Hypothetical

This issue has moved beyond theoretical discussions.

In July 2026, the FTC announced a $12 million penalty against Edwards Lifesciences and Genesis MedTech involving alleged violations of pre-merger reporting requirements. The case is as an important enforcement precedent for deals structured to avoid an HSR filing.

The issue had already attracted political and regulatory attention earlier in 2026.

In February, three US Senators formally asked federal regulators to investigate several technology transactions involving AI companies, including deals involving Meta and Scale AI, Google and Windsurf, and Nvidia and Groq.

The important takeaway for founders is that regulators are paying attention to the substance of these transactions.

A transaction should not be treated as outside antitrust review simply because the documents are labeled as employment and licensing agreements.

The Company You Leave Behind Still Exists

A reverse acquihire can create an unusual corporate structure.

Your team leaves.

Your technology is licensed.

But the original company may continue to exist.

That company may still be owned by investors and shareholders who were not included in the hiring arrangement.

There are several concerns:

• Minority shareholders may remain invested in a company that has lost much of its operating business.
• The intellectual property license needs a genuine independent valuation.
• Directors still owe fiduciary duties to shareholders who remain behind.
• Regulators or shareholders may later examine how the transaction was structured, valued, and approved.

This is why founders should not view the transaction simply as a way to move their employees to another company.

It is still a corporate transaction that affects the interests of people who may not be leaving with you.

The IP License Deserves Serious Attention

The intellectual property license can be one of the most important parts of the transaction.

Founders may be tempted to treat the licensing agreement as routine paperwork because the main attraction is the employment offer.

That can be a mistake.

If the startup is licensing valuable technology for less than its fair value, shareholders who remain in the company could potentially argue that the transaction harmed them.

Obtain an independent valuation rather than simply accepting the acquirer’s proposed licensing price.

The valuation should therefore be considered independently from the employment arrangements.

Board Approval Still Matters

A reverse acquihire may feel different from a traditional acquisition.

That does not mean the board can treat it like an ordinary personnel decision.

Directors still have fiduciary duties to the company’s shareholders.

Board members who approve the transaction may face personal exposure if the deal is approved without an appropriate process.

A proper process should therefore document how the board evaluated the transaction, including its impact on shareholders who are not being hired by the other company.

Speed Can Become the Biggest Risk

One of the main attractions of a reverse acquihire is speed.

There may be no traditional acquisition process and potentially no lengthy waiting period associated with a conventional merger.

But that speed can also mean important diligence gets compressed.

Transactions designed for speed may skip processes that would otherwise identify legal or valuation problems. A later investigation could then examine the deal after the startup’s team has already moved to the new company.

For founders, moving quickly should not mean skipping the legal analysis.

Major Investors May Also Have Rights

Your company’s existing financing documents may impose additional requirements.

Depending on the company’s agreements, major investors may have consent rights or other protections that could be triggered by a transaction involving substantially all of the company’s people or intellectual property.

Confirm whether major investors have consent rights before signing a hire-and-license arrangement.

Reviewing those provisions early can prevent a transaction from becoming unnecessarily complicated after negotiations have already progressed.

Common Founder Mistakes

• Treating a reverse acquihire as “just an employment deal”: Regulators may examine the substance of the transaction rather than relying on the labels used in the agreements.
• Signing an IP license without an independent valuation: An underpriced license may create concerns for shareholders who remain invested in the original company.
• Skipping formal board and investor approval: A transaction that moves the company’s key people and technology should be treated as a significant corporate transaction, not simply a personnel decision.
• Prioritizing speed over diligence: Moving quickly may feel attractive, but skipping antitrust, valuation, governance, and shareholder analysis can create greater problems later.

10-Minute Reverse Acquihire Self Check

• Has counsel performed an HSR and antitrust analysis regardless of how the transaction is structured?
• Has the company’s intellectual property been independently valued?
• Has the board formally reviewed and approved the transaction?
• Have fiduciary duties to remaining shareholders been considered and documented?
• Do major investors have consent or approval rights?
• Do I understand what happens to shareholders and employees who are not part of the transaction?
• Have we reviewed whether regulators are scrutinizing similar transactions?

If you cannot answer yes to all of these, you are exposing yourself and your board to liability the moment the deal closes.

Bottom Line

A reverse acquihire may offer a fast alternative to a traditional acquisition, but the structure does not eliminate the legal issues associated with moving a startup’s people and technology to another company. Antitrust analysis, intellectual property valuation, board duties, investor rights, and the interests of remaining shareholders all deserve careful attention.

The safest approach is to evaluate the transaction based on what it actually accomplishes, not simply what the agreements call it.

Ready to Structure the Deal Before Regulators Take a Closer Look?

Schedule a free 30-minute call with our team to discuss your proposed transaction, antitrust concerns, intellectual property licensing, board approvals, and the legal issues that should be addressed before you sign.

Book here: Initial Consultation with Primum Law Group